Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:04 AM
Study NCT ID:
NCT05298020
Status:
UNKNOWN
Last Update Posted:
2022-03-28
First Post:
2022-03-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-18
First Submit QC Date:
None
Study First Post Date:
2022-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-18
Last Update Post Date:
2022-03-28
Last Update Post Date Type:
ACTUAL